Connect
MJA
MJA

Pharmaceutical preparations

Letters

Medication to prevent breast cancer — too much to swallow?

Jerry R Greenfield and Ann I McCormack

Med J Aust 2012; 196 (5): 314

Perspectives

Does antibiotic use in farmed animals pose a risk to human health? – Yes

Peter J Collignon

Med J Aust 2012; 196 (5): 302

Perspectives

Does antibiotic use in farmed animals pose a risk to human health? — No

Stephen W Page

Med J Aust 2012; 196 (5): 303

Letters

A to X: the problem of categorisation of drugs in pregnancy — an Australian perspective

Ronald P Batagol

Med J Aust 2012; 196 (3): 172

Letters

A to X: the problem of categorisation of drugs in pregnancy — an Australian perspective

Adam P Morton

Med J Aust 2012; 196 (3): 172

Letters

A to X: the problem of categorisation of drugs in pregnancy — an Australian perspective

Debra S Kennedy

Med J Aust 2012; 196 (3): 172-173

Editorials

Challenges and opportunities for the Pharmaceutical Benefits Scheme

Philip M Clarke

Med J Aust 2012; 196 (3): 153-154

Letters

A Pandora’s box: sustainable pharmaceutical supply

Robert Pearce, Simon Quilty, Jacqueline Kewley and Lisa M Harris

Med J Aust 2012; 196 (3): 170-171

Research

A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older

Tessa K Morgan, Margaret Williamson, Marie Pirotta, Kay Stewart, Stephen P Myers and Joanne Barnes

Med J Aust 2012; 196 (1): 50-53 Free

Perspectives

What’s in a name? Brand name confusion and generic medicines

Shane L Carney, Madlen Gazarian, Justin T Denholm, David M Reith, Robert K Penhall, Christine R Jenkins, Kay A Wilhelm, Paul A Komesaroff, Mary M Osborn and Richard O Day

Med J Aust 2011; 195 (11): 650-651

Letters

Implementing US-style anti-fraud laws in the Australian pharmaceutical and health care industries

Alain Braillon

Med J Aust 2011; 195 (10): 585

Perspectives

A to X: the problem of categorisation of drugs in pregnancy — an Australian perspective

Debra S Kennedy

Med J Aust 2011; 195 (10): 572-574

Editorials

A most trusted profession ...?

Anthony J Smith and David A Newby

Med J Aust 2011; 195 (9): 490-491

Letters

Serious morbidity associated with misuse of over-the-counter codeine–ibuprofen analgesics

Rozemary Karamatic, John Croese and Enrico Roche

Med J Aust 2011; 195 (9): 516

Letters

Death and morbidity from supratherapeutic dosing of colchicine

Michelle Sweidan, James F Reeve and Kitty Yu

Med J Aust 2011; 195 (9): 517

Letters

Death and morbidity from supratherapeutic dosing of colchicine

Nicholas A Buckley and Simone O P Rossi

Med J Aust 2011; 195 (9): 517

Research

Stroke risk and NSAIDs: an Australian population-based study

Gillian E Caughey, Elizabeth E Roughead, Nicole Pratt, Graeme Killer and Andrew L Gilbert

Med J Aust 2011; 195 (9): 525-529 Free

Editorials

NSAIDs and stroke risk

David J Blacker

Med J Aust 2011; 195 (9): 488

Perspectives

The downsides of antidepressants

Ray Moynihan

Med J Aust 2011; 195 (8): 441

Editorials

Why is disulfiram not on the PBS?

Wendy L Lipworth, Alex D Wodak, Paul S Haber and Richard O Day

Med J Aust 2011; 195 (7): 371-372

Letters

Pharmacogenetic screening of Indigenous Australians

Joseph D Tucci

Med J Aust 2011; 195 (7): 386-387 Free

Editorials

Safety of incretin-based therapies for type 2 diabetes

Timothy M E Davis

Med J Aust 2011; 195 (6): 312-313

Letters

Should opioids be used for chronic non-cancer pain?

Mark S Awerbuch

Med J Aust 2011; 195 (5): 264-265

Research

Persistence with a single pill versus two pills of amlodipine and atorvastatin: the Australian experience, 2006–2010

Leon A Simons, Michael Ortiz and Gordon Calcino

Med J Aust 2011; 195 (3): 134-137 Free

Editorials

Improving Aboriginal and Torres Strait Islander people’s access to medicines — the QUMAX program

Sophie Couzos, Vicki Sheedy and Dea Delaney Thiele

Med J Aust 2011; 195 (2): 62-63 Free